These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3793699)

  • 1. Role of verapamil in experimentally induced myocardial infarction in dog.
    Siddiqui MA; Mirza MR; Aziz M; Verma AK
    J Assoc Physicians India; 1986 Sep; 34(9):639-40. PubMed ID: 3793699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reduction in the size of a myocardial infarct with the use of verapamil].
    Ribeiro LG; Maroko PR
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():1-4. PubMed ID: 7325857
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental infarction studies.
    Maroko PR
    Clin Invest Med; 1980; 3(1-2):139-42. PubMed ID: 7471538
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of verapamil (isoptin) on experimental myocardial infarction in rhesus monkeys.
    Chakravarti RN; Sharma PL; Anand IS; Manga PA; Wahi PL
    Indian J Med Res; 1981 Apr; 73():625-32. PubMed ID: 7262936
    [No Abstract]   [Full Text] [Related]  

  • 5. Verapamil and nifedipine limit infarct size in the dog.
    Downey JM; Hearse DJ; Yoshida S; Maxwell MP; Yellon DM
    Adv Myocardiol; 1985; 6():529-43. PubMed ID: 3992049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial viability in acute myocardial infarction and verapamil].
    Iliceto S; Rizzon P
    Cardiologia; 1994 Dec; 39(12 Suppl 1):187-90. PubMed ID: 7634265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological bases of the effect of verapamil on the heart in experimental acute coronary failure].
    Tereshchenko VP; Nizhenkovskaia IV
    Vrach Delo; 1983 May; (5):19-21. PubMed ID: 6880160
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
    Galenko-Iaroshevskiĭ PA; Melkumova ER; Bartashevich VV; Uvarov AV; Turovaia AIu; Khankoeva AI; Galygo DS
    Biull Eksp Biol Med; 1996 Dec; 122(12):642-4. PubMed ID: 9280462
    [No Abstract]   [Full Text] [Related]  

  • 10. [Verapamil in the acute phase of myocardial infarct].
    Aquaro G; Ravera A; Belli R; Rey L; Possavino G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2139-41. PubMed ID: 7185380
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of D-600 (methoxy-verapamil) on mortality and infarction size after coronary occlusion in rats].
    Ribeiro LG; Spadaro J; Brandon TA; Kim HS; Titus JL; Maroko PR; Miller RR
    Arq Bras Cardiol; 1981 Aug; 37(2):85-8. PubMed ID: 7348179
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
    Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Brenna S; Bonacina E; Vignati S
    Fundam Clin Pharmacol; 2004 Dec; 18(6):657-67. PubMed ID: 15548237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of the size of the ischemic area on the beneficial effects of drugs capable of protecting the ischemic myocardium].
    Ribeiro LG; Faria DB; Cheung WM; Maroko PR
    Arq Bras Cardiol; 1982 Nov; 39(5):297-301. PubMed ID: 7186382
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative effects of obsidan and isoptin on the size of myocardial infarction].
    Agaev MM
    Kardiologiia; 1984 Oct; 24(10):63-6. PubMed ID: 6521185
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia.
    Braunwald E; DeBoer LW; Glogar DH; Darsee JR; Ertl G; Ingwall JS; Kloner RA
    Acta Med Scand Suppl; 1981; 651():123-32. PubMed ID: 7034471
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
    Kaur AH; Singh M; Singh J; Jain K
    Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size.
    Anand IS; Sharma PL; Chakravarti RN; Wahi PL
    Adv Myocardiol; 1980; 2():425-33. PubMed ID: 7423056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Protection of the ischemic myocardium: experiences with verapamil].
    Ferrari G; Zerboni S; Noseda G; Bonini W; Bassi G; Porro G
    Boll Soc Ital Cardiol; 1981; 26(12):2371-6. PubMed ID: 7185407
    [No Abstract]   [Full Text] [Related]  

  • 19. The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
    Alps BJ; Calder C; Wilson A
    Arzneimittelforschung; 1983; 33(6):868-76. PubMed ID: 6684443
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-ischemic therapy with verapamil. Improving prognosis by secondary prevention after acute myocardial infarct].
    Dotzer F; Gromer H
    Fortschr Med; 1993 May; 111(14):245-8. PubMed ID: 8335304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.